These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20855728)

  • 1. Aziridine-2,3-dicarboxylate-based cysteine cathepsin inhibitors induce cell death in Leishmania major associated with accumulation of debris in autophagy-related lysosome-like vacuoles.
    Schurigt U; Schad C; Glowa C; Baum U; Thomale K; Schnitzer JK; Schultheis M; Schaschke N; Schirmeister T; Moll H
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5028-41. PubMed ID: 20855728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases.
    Schad C; Baum U; Frank B; Dietzel U; Mattern F; Gomes C; Ponte-Sucre A; Moll H; Schurigt U; Schirmeister T
    Antimicrob Agents Chemother; 2016 Feb; 60(2):797-805. PubMed ID: 26596939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aziridine-2,3-dicarboxylates, peptidomimetic cysteine protease inhibitors with antileishmanial activity.
    Ponte-Sucre A; Vicik R; Schultheis M; Schirmeister T; Moll H
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2439-47. PubMed ID: 16801424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
    Schirmeister T
    J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aziridide-based inhibitors of cathepsin L: synthesis, inhibition activity, and docking studies.
    Vicik R; Busemann M; Gelhaus C; Stiefl N; Scheiber J; Schmitz W; Schulz F; Mladenovic M; Engels B; Leippe M; Baumann K; Schirmeister T
    ChemMedChem; 2006 Oct; 1(10):1126-41. PubMed ID: 16933358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New aziridine-based inhibitors of cathepsin L-like cysteine proteases with selectivity for the Leishmania cysteine protease LmCPB2.8.
    Fey P; Chartomatsidou R; Kiefer W; Mottram JC; Kersten C; Schirmeister T
    Eur J Med Chem; 2018 Aug; 156():587-597. PubMed ID: 30029081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteine protease inhibitors as chemotherapy: lessons from a parasite target.
    Selzer PM; Pingel S; Hsieh I; Ugele B; Chan VJ; Engel JC; Bogyo M; Russell DG; Sakanari JA; McKerrow JH
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11015-22. PubMed ID: 10500116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aziridinyl peptides as inhibitors of cysteine proteases: effect of a free carboxylic acid function on inhibition.
    Schirmeister T; Peric M
    Bioorg Med Chem; 2000 Jun; 8(6):1281-91. PubMed ID: 10896108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aziridine analogs of [[trans-(epoxysuccinyl)-L-leucyl]amino]-4-guanidinobutane (E-64) as inhibitors of cysteine proteases.
    Martichonok V; Plouffe C; Storer AC; Ménard R; Jones JB
    J Med Chem; 1995 Aug; 38(16):3078-85. PubMed ID: 7636871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with cathepsin L inhibitor potentiates Th2-type immune response in Leishmania major-infected BALB/c mice.
    Zhang T; Maekawa Y; Sakai T; Nakano Y; Ishii K; Hisaeda H; Dainichi T; Asao T; Katunuma N; Himeno K
    Int Immunol; 2001 Aug; 13(8):975-82. PubMed ID: 11470767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the evolution of programmed cell death: apoptosis of the unicellular eukaryote Leishmania major involves cysteine proteinase activation and mitochondrion permeabilization.
    Arnoult D; Akarid K; Grodet A; Petit PX; Estaquier J; Ameisen JC
    Cell Death Differ; 2002 Jan; 9(1):65-81. PubMed ID: 11803375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiplasmodial activity of a cysteine protease-inhibiting biotinylated aziridine-2,3-dicarboxylate.
    Gelhaus C; Vicik R; Hilgenfeld R; Schmidt CL; Leippe M; Schirmeister T
    Biol Chem; 2004 May; 385(5):435-8. PubMed ID: 15196005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biogenesis of Leishmania major-harboring vacuoles in murine dendritic cells.
    Körner U; Fuss V; Steigerwald J; Moll H
    Infect Immun; 2006 Feb; 74(2):1305-12. PubMed ID: 16428780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195.
    Guedes CES; Dias BRS; Petersen ALOA; Cruz KP; Almeida NJ; Andrade DR; Menezes JPB; Borges VM; Veras PST
    Mem Inst Oswaldo Cruz; 2018 Feb; 113(4):e170345. PubMed ID: 29412342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ultrastructure of the parasitophorous vacuole formed by Leishmania major.
    Castro R; Scott K; Jordan T; Evans B; Craig J; Peters EL; Swier K
    J Parasitol; 2006 Dec; 92(6):1162-70. PubMed ID: 17304790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp.
    Calixto SL; Glanzmann N; Xavier Silveira MM; da Trindade Granato J; Gorza Scopel KK; Torres de Aguiar T; DaMatta RA; Macedo GC; da Silva AD; Coimbra ES
    Chem Biol Interact; 2018 Sep; 293():141-151. PubMed ID: 30098941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of aziridine-containing cysteine protease inhibitors with improved potency: studies on inhibition mechanism.
    Vicik R; Helten H; Schirmeister T; Engels B
    ChemMedChem; 2006 Sep; 1(9):1021-8. PubMed ID: 16933238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of intracellular cysteine proteinases, in particular cathepsin B, in degradation of collagen in periosteal tissue explants.
    Creemers LB; Hoeben KA; Jansen DC; Buttle DJ; Beertsen W; Everts V
    Matrix Biol; 1998 Mar; 16(9):575-84. PubMed ID: 9569125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania major: molecular modeling of cysteine proteases and prediction of new nonpeptide inhibitors.
    Selzer PM; Chen X; Chan VJ; Cheng M; Kenyon GL; Kuntz ID; Sakanari JA; Cohen FE; McKerrow JH
    Exp Parasitol; 1997 Nov; 87(3):212-21. PubMed ID: 9371086
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    McDonald C; Smith D; Di Cristina M; Kannan G; Dou Z; Carruthers VB
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32051238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.